Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF | Zendy

C E Chiang | Zendy; Marnix Goethals | Zendy; James O’Neill | Zendy; Lisa NaditchBrûlé | Zendy; Sandrine Brette | Zendy; Habib Gamra | Zendy; O. Zharinov | Zendy; Philippe Gabríel Steg | Zendy

Open Access

Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF

Author(s) -

C E Chiang,

Marnix Goethals,

James O’Neill,

Lisa NaditchBrûlé,

Sandrine Brette,

Habib Gamra,

O. Zharinov,

Philippe Gabríel Steg

Publication year - 2013

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eut204

Subject(s) - medicine , paroxysmal atrial fibrillation , atrial fibrillation , cardiology , intensive care medicine

International atrial fibrillation (AF) guidelines have defined optimal drugs for patients with various underlying diseases, but the extent to which real-life practice complies with these guidelines is unknown. This study aimed to evaluate the appropriate use of antiarrhythmic drugs (AADs) in patients with paroxysmal and persistent AF from the RealiseAF survey, according to the 2006 American College of Cardiology/American Heart Association/European Society of Cardiology AF guidelines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research